Products for Research Use Only

9-PAHSA

CAT: 0804-HY-120657-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-120657-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
9-PAHSA is an orally available anti-inflammatory lipid that lowers blood sugar and reduces inflammation. 9-PAHSA also improved carotid vascular calcification and attenuates cardiac hypertrophy and dysfunction in db/db mice. 9-PAHSA increases the viability of steatosis primary mouse hepatocytes (PMH) . 9-PAHSA can be used in research on diabetes, inflammation, and cardiovascular disease[1][2].
CAS Number
1481636-31-0
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H331, H336, H351, H361, H372, H412
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/9-pahsa.html
Purity
99.88
Solubility
DMSO : 5 mg/mL (ultrasonic; warming; heat to 80°C)
Smiles
OC(CCCCCCCC(CCCCCCCCC)OC(CCCCCCCCCCCCCCC)=O)=O
Molecular Formula
C34H66O4
Molecular Weight
538.89
Precautions
H302, H315, H319, H331, H336, H351, H361, H372, H412
References & Citations
[1]Wang YM, et al. 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice. Front Pharmacol. 2021 Nov 15;12:754387.|[2]Schultz Moreira AR, et al. 9-PAHSA Prevents Mitochondrial Dysfunction and Increases the Viability of Steatotic Hepatocytes. Int J Mol Sci. 2020 Nov 5;21 (21) :8279.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported